Targeted minor histocompatibility antigen typing to estimate graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
- 16 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 56 (12), 3024-3028
- https://doi.org/10.1038/s41409-021-01459-8
Abstract
Graft-versus-host disease (GVHD) is a critical complication after allogeneic haematopoietic stem cell transplantation induced by genetic differences in donor–recipient pairs. Rigorous HLA matching has reduced GVHD, but severe GVHD still occurs. Minor histocompatibility antigens (mHAs) are another source of GVHD inducers. We designed a multi-mHA panel with 35 valid mHA loci and retrospectively analyzed 391 donor–recipient pairs with the anticipation of implementing mHA typing into clinical practice to optimize donor selection. Results showed the total mismatching in mHA loci in this panel, as well as mismatching in the GVH direction in unmatched-related recipients (UMRs) were 1.8 times and 1.3 times as those in matched-sibling recipients (MSRs) (p = 4.1e-4, p = 0.012, respectively). There was no significant association between mHA loci mismatching and grades II-IV acute GVHD (aGVHD), III-IV aGVHD, extensive chronic GVHD (cGVHD), or relapse in neither group. UMRs had an increased cumulative incidence of II-IV aGVHD (p = 0.002), but there was no statistical difference of the incidences in severe aGVHD or cGVHD (p = 0.093; p = 0.930). This is a preliminary study to explore GVHD risks brought by mHA loci mismatching in both unmatched-related recipients and matched-full-sibling recipients. Our results confirmed that stringent HLA matching is the key to reduce the risks for GVHD.Keywords
Funding Information
- Shandong Nature Science Fund
This publication has 19 references indexed in Scilit:
- MHC class I–associated peptides derive from selective regions of the human genomeJCI Insight, 2016
- Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patientsBone Marrow Transplantation, 2016
- Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune TargetsFrontiers in Immunology, 2016
- Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancersLeukemia, 2016
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International ConsortiumTransplantation and Cellular Therapy, 2015
- Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptidesNature Communications, 2014
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationThe New England Journal of Medicine, 2010
- Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantationBlood, 2006
- Chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2003
- Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow TransplantAnnual Review of Medicine, 2003